Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
R&D Inquiry Quote
Contact Us

Apta-Index™: Tumor-derived endothelial cells (tRRL) (ID# 384)

Back to Search Results

Tumor-derived endothelial cells (tRRL) (ID# 384)

Tumor-derived endothelial cells (tRRL)
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Peptide Tumor-derived endothelial cells (TDECs) Cells N/A nM (reported value) PBS was used for Flow Cytometry assays.
For radiometric binding assays, cell media varied according to cell line. See ref. for details.
N/A If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-TyrCysGlyGlyArgArgLeuGlyGlyCys-3'
10 1141.40 g/mole

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

X Lu et al. Use of radioiodinated peptide arg-arg-leu targeted to neovascualrization as well as tumor cells in molecular tumor imaging. Chin J Cancer Res 24(2012): 52-59.

Have your aptamer oligo synthesized by one of our AFFILIATES

Community Feedback

Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™